Tatsuo Takahashi

Tatsuo Takahashi

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2008
Verified
Journal Article
Closed access
MNMasaaki Nomura
Masaaki Nomura
TTTatsuo Takahashi
Tatsuo Takahashi
AUAimi Uesugi
Aimi Uesugi
RTReiko Tanaka
Reiko Tanaka
SKShinjiro Kobayashi
Shinjiro Kobayashi

1 January 2013 in Molecular Medicine
Verified
Journal Article
Open access
TTTatsuo Takahashi
Tatsuo Takahashi
SKSayaka Katsuta
Sayaka Katsuta
YTYusuke Tamura
Yusuke Tamura
NNNozomi Nagase
Nozomi Nagase
KSKeita Suzuki
Keita Suzuki
SKShinjiro Kobayashi
Shinjiro Kobayashi
Rheumatoid arthritis (RA) is a chronic inflammatory synovitis that leads to the destruction of bone and cartilage. The receptor for advanced glycation end products (RAGE) is a multiligand membrane-bound receptor for high-mobility group box-1 (HMGB1) associated with development of RA by inducing production of proinflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1 and IL-6. We developed a bone-targeting therapeutic agent by tagging acidic oligopeptide to a nonmem-brane-bound form of RAGE (endogenous secretory RAGE [esRAGE]) functioning as a decoy receptor. We assessed its tissue distribution and therapeutic effectiveness in a murine model of collagen-induced arthritis (CIA). Acidic oligopeptide-tagged esRAGE (D6-esRAGE) was localized to mineralized region in bone, resulting in the prolonged retention of more than 1 wk. Weekly administration of D6-esRAGE with a dose of 1 mg/kg to RA model mice significantly ameliorated inflammatory arthritis, synovial hyperplasia, cartilage destruction and bone destruction, while untagged esRAGE showed little effectiveness. Moreover, D6-esRAGE reduced plasma levels of proinflammatory cytokines including TNF-α, IL-1 and IL-6, while esRAGE reduced the levels of IL-1 and IL-6 to a lesser extent, suggesting that production of IL-1 and IL-6 reduced along the blockade of HMGB1 receptor downstream signals by D6-esRAGE could be attributed to remission of CIA. These findings indicate that D6-esRAGE enhances drug delivery to bone, leading to rescue of clinical and pathological lesions in murine CIA.

20 December 2014 in BMC Genomic Data
Verified
Journal Article
Open access
PDF file
MOMasanori Ohmoto
Masanori Ohmoto
TTTatsuo Takahashi
Tatsuo Takahashi
YKYoko Kubota
Yoko Kubota
SKShinjiro Kobayashi
Shinjiro Kobayashi
YMYasuhide Mitsumoto
Yasuhide Mitsumoto
This study investigated whether polymorphisms of the ankyrin repeat and kinase domain containing 1 gene (ANKK1), which is adjacent to the dopamine D2 receptor gene (DRD2), and the dopamine transporter (SLC6A3) and cytochrome P450 2A6 (CYP2A6) genes influence smoking cessation and nicotine dependence in a Japanese population. In 96 current and former smokers, genotyping frequencies for the ANKK1/DRD2 TaqIA, SLC6A3 VNTR, and CYP2A6 polymorphisms were subjected to chi-square analysis, and regression analyses were used to determine the association of the genotypes of current smokers with a Heavy Smoking Index, in addition to evaluating the effect of the subjects’ smoking history on the association. Genotyping results suggested that nicotine dependence among current smokers homozygous for the SLC6A3 10r allele was lower than that of smokers carrying the minor alleles, and that the CYP2A6 polymorphism might mediate this association. Furthermore, the age at which current smokers began smoking might moderate the association between their genetic polymorphisms and nicotine dependence. This study provides preliminary findings on the influence of genetic variants on the smoking phenotypes in a Japanese population.

Verified
Journal Article
Open access
PDF file
YKYuji Kanazawa
Yuji Kanazawa
TTTatsuo Takahashi
Tatsuo Takahashi
MNMamoru Nagano
Mamoru Nagano
SKSatoshi Koinuma
Satoshi Koinuma
YSYasufumi Shigeyoshi
Yasufumi Shigeyoshi
The pathogenesis of sarcopenia includes the dysfunction of calcium homeostasis associated with the sarcoplasmic reticulum; however, the localization in sarcoplasmic reticulum-related factors and differences by myofiber type remain unclear. Here, we investigated the effects of aging on sarcoplasmic reticulum-related factors in the soleus (slow-twitch) and gastrocnemius (fast-twitch) muscles of 3- and 24-month-old male C57BL/6J mice. There were no notable differences in the skeletal muscle weight of these 3- and 24-month-old mice. The expression of Atp2a1, Atp2a2, Sln, and Pln increased with age in the gastrocnemius muscles, but not in the soleus muscles. Subsequently, immunohistochemical analysis revealed ectopic sarcoplasmic reticulum calcium ion ATPase (SERCA) 1 and SERCA2a immunoreactivity only in the gastrocnemius muscles of old mice. Histochemical and transmission electron microscope analysis identified tubular aggregate (TA), an aggregation of the sarcoplasmic reticulum, in the gastrocnemius muscles of old mice. Dihydropyridine receptor α1, ryanodine receptor 1, junctophilin (JPH) 1, and JPH2, which contribute to sarcoplasmic reticulum function, were also localized in or around the TA. Furthermore, JPH1 and JPH2 co-localized with matrix metalloproteinase (MMP) 2 around the TA. These results suggest that sarcoplasmic reticulum-related factors are localized in or around TAs that occur in fast-twitch muscle with aging, but some of them might be degraded by MMP2.

1 April 2009
Verified
Journal Article
Closed access
MTMakiko Takaya
Makiko Takaya
MNMasaaki Nomura
Masaaki Nomura
TTTatsuo Takahashi
Tatsuo Takahashi
YKYoko Kondo
Yoko Kondo
KLKyung-Tae Lee
Kyung-Tae Lee
SKShinjiro Kobayashi
Shinjiro Kobayashi

20 July 2020 in Traditional & Kampo Medicine
Verified
Journal Article
Closed access
PDF file
TTTatsuo Takahashi
Tatsuo Takahashi
KHKenta Hori
Kenta Hori
EYEri Yoshida
Eri Yoshida
YIYuri Ikeda‐Matsuo
Yuri Ikeda‐Matsuo
TSTsutomu Shimada
Tsutomu Shimada
SKShinjiro Kobayashi
Shinjiro Kobayashi